Newly Diagnosed AML With FLT3 Activating Mutations
1 clinical trials · Condition
◉ Watch Newly Diagnosed AML With FLT3 Activating Mutations
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations (NCT02283177) | Arog Pharmaceuticals, Inc. | 2015-01-01 |
Track Newly Diagnosed AML With FLT3 Activating Mutations automatically
Every clearance here is in the API, with alerts when new ones post.